Lumida
/SGHT
⌘K
Sight Sciences Inc

Sight Sciences Inc

SGHT
$8.14USD↑+1.69%+0.13 today

MARKET CAP

448.4M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$8 – $8

52W RANGE

$3
$9

AI Summary

Stalk
Buy NowMedium

SGHT remains in a Stage 2 advancing phase, underpinned by an active Lockout Rally that has driven price above the 9 and 21 EMAs on rising volume. The medium-term bias is bullish, supported by a HH/HL sequence off the March low, while the long-term trend stays intact. Short-term execution is favorable now under the Lockout Rally override, so participation at shallow pullbacks into the EMAs aligns with continuation dynamics.

  • ↑Q2 2026 revenue $23.4M (+20% YoY) with 91% gross margin
  • ↑Interventional dry eye segment at $2.7M (+704% YoY) across 176 accounts
  • ↓Earnings yield deeply negative and net loss $4.4M despite 63% improvement
Full analysis →

Buying

3

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY3.08 M16.71 M+251.18 K+56.5%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY397.56 K2.15 M+259.04 K+312.6%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY216.31 K1.17 M+81.00 K+129.8%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL212.66 K1.15 M+-80.70 K+4.2%0.00%
MM

Millennium Management LLC

Q2 2026

SELL75.31 K408.16 K+-184.72 K-58.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL46.23 K269.97 K+-4.41 K+44.9%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL16.12 K87.40 K+-82.61 K-76.5%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL154.00835.00+-410.00-60.7%0.00%